Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chongmin Ren"'
Autor:
Bingxin Zheng, Xiangchen Sun, Li Zhang, Guojian Qu, Chongmin Ren, Peng Yan, Chuanli Zhou, Bin Yue
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 57 (2024)
Abstract The cure rates for osteosarcoma have remained unchanged in the past three decades, especially for patients with pulmonary metastasis. Thus, a new and effective treatment for metastatic osteosarcoma is urgently needed. Anlotinib has been repo
Externí odkaz:
https://doaj.org/article/1dc757032990401db2371c149708be37
Autor:
Jia Liu, Ranran Zhang, Dahai Wang, Yi Lin, Cui Bai, Nana Nie, Shan Gao, Qiuye Zhang, Hong Chang, Chongmin Ren
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background To investigate the role of circNFIB in the alleviation of myocardial fibrosis by endogenous sulfur dioxide (SO2). Methods We stimulated cultured neonatal rat cardiac fibroblasts with transforming growth factor-β1 (TGF-β1) and de
Externí odkaz:
https://doaj.org/article/705e3fcce7974ffbb364e2191ee7d4a6
Autor:
Bingxin Zheng, Keliang Song, Lingling Sun, Yang Gao, Yan Qu, Chongmin Ren, Peng Yan, Wenfang Chen, Wei Guo, Chuanli Zhou, Bin Yue
Publikováno v:
Cell & Bioscience, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Background Pulmonary metastasis is the main cause of poor prognosis in osteosarcoma. Sialic acid-bound immunoglobulin lectin 15 (Siglec-15) has been demonstrated to be obviously correlated with pulmonary metastasis in osteosarcoma patients.
Externí odkaz:
https://doaj.org/article/67205ed6114445a9ba20be88dd8186d8
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 47, Iss 1, Pp 3359-3367 (2019)
We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Chongmin Ren, Jia Liu, Bingxin Zheng, Peng Yan, Yuerong Sun & Bin Yue (2019) The circular RNA circ-ITCH acts as a tum
Externí odkaz:
https://doaj.org/article/39cf2325b41f4352a680c0ced7e4d751
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The survival rate of osteosarcoma, the most prevalent primary bone tumor, has not been effectively improved in the last 30 years. Hence, new treatments and drugs are urgently needed. Antiangiogenic therapy and immunotherapy have good antitumor effect
Externí odkaz:
https://doaj.org/article/b4e720611f714ef69a5ebf9d4edccaf4
Publikováno v:
Advances in Medical Sciences. 67:187-195
Sialic acid-bound immunoglobulin lectin 15 (Siglec-15) plays a crucial role in many kinds of tumors. The relationship between Siglec-15 and the prognosis of osteosarcoma patients and its role in the apoptosis and pyroptosis of osteosarcoma cells are
Background: Giant cell tumor of bone is a common primary borderline bone tumor, while giant cell tumor of bone in the extremities are generally not very large. Because most tumors have already been controlled by some treatments at the time of pain or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::906aa761f2e9757d1ef80804ff204ac3
https://doi.org/10.21203/rs.3.rs-606935/v1
https://doi.org/10.21203/rs.3.rs-606935/v1
Publikováno v:
International Journal of Oncology. 50:477-486
Bortezomib, formerly known as PS341, is a novel proteasome inhibitor with in vitro and in vivo antineoplastic effects in many malignancies. However, diverse antitumor mechanisms of bortezomib have been identified in many investigations and preclinica
Publikováno v:
Artificial cells, nanomedicine, and biotechnology. 47(1)
Autor:
Chongmin Ren1,2, Tingting Ren1,2, Kang Yang1,2, Shidong Wang1,2, Xing Bao1,2, Fan Zhang1,2, Wei Guo1,2 bonetumor@163.com
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 3/11/2016, Vol. 35, p1-14. 14p.